Illness	Number of cases
Hyperplasia of prostate (N40)	70
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	52
Calculus of kidney and ureter - Calculus of kidney (N20.0)	52
Acute tubulo-interstitial nephritis (N10)	48
Malignant neoplasm of prostate (C61)	47
Malignant neoplasm of testis (C62.1)	46
Calculus of kidney and ureter - Calculus of ureter (N20.1)	43
Cystitis (N30.2)	32
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	29
Malignant neoplasm of renal pelvis (C65)	27

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	303
Computer-assisted analysis of the images with 3D-analysis (3-990)	142
Use of an imaging procedure during an operation (3-992)	135
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	117
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	92
Insertion, exchange or removal of a ureteral stent (8-137.00)	87
Computed tomography of the abdomen with contrast medium (3-225)	82
Computed tomography (CT) of the pelvis without contrast medium (3-206)	81
Computed tomography (CT) of the abdomen without contrast medium (3-207)	77
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	74

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
158	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
34	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
32	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB19	Nursing professionals
HB03	Physical therapist / physiotherapist (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB18	Emergency paramedics (m/f) (training period 3 years)
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)